{"title":"Designating Vulnerability of Atherosclerotic Plaques","authors":"B. Bilen","doi":"10.5772/intechopen.90664","DOIUrl":"https://doi.org/10.5772/intechopen.90664","url":null,"abstract":"Microcalcification is an indication of vulnerability of plaques in humans. With conventional imaging modalities, screening of micrometer-sized structures in vivo with high spatial resolution has not been achieved. The goal of this study is to evaluate the potentials of micro-computed tomography (micro-CT), scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS), time-resolved fluorescence spectroscopy (TRFS), scanning acoustic microscopy (SAM), and photoacoustic microscopy (PAM) in the determination of atherosclerotic plaques with microcalcifications and, therefore, the prospect of constructing a modality on a cath-eter system. The discrimination of microcalcifications within the fibrocalcific plaques and, therefore, the effectivity of these imaging techniques are discussed. The potential of quantum dots (QDs) in biological imaging is also elucidated since they attract great attention as contrast and therapeutic agents, owing unique properties including good light stability, low toxicity, strong fluorescence intensity, and changing emission wavelength with QD size, ranging from 10 to 100 Å in radius.","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125250729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Muthuraman, N. Rishitha, N. Paramakrishnan, B. Mahendran, M. Ramesh
{"title":"Role of Lipid Peroxidation Process in Neurodegenerative Disorders","authors":"A. Muthuraman, N. Rishitha, N. Paramakrishnan, B. Mahendran, M. Ramesh","doi":"10.5772/intechopen.81188","DOIUrl":"https://doi.org/10.5772/intechopen.81188","url":null,"abstract":"Lipid peroxidation is one of the primary events of the cell injury process. In pathophysiological condition, it is undergoing the initiation of organ damage. Various free radicals are playing a key role in this lipid peroxidation process. Free radical associated organ damage involves the three major phases, that is, initiation, propagation and termination. The primary source of various free radical formations is mediated through the pathophysiological function of mitochondria. Lipid peroxidation is contributed to the multiple neurodegenerative disorders. Thus, the various endogenous cellular anti-oxidant systems are regulated lipid peroxidation process and control the neurodegenerative action. Some of the molecules are targeted to attenuate the lipid peroxidation and their mediators for the prevention of neurodegeneration.","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123834634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Filipič, L. Gradišnik, Klemen Rihar, A. Pereyra, Damir Đermić, H. Mazija
{"title":"Royal Jelly and Human Interferon-Alpha (HuIFN-αN3) Affect Proliferation, Glutathione Level, and Lipid Peroxidation in Human Colorectal Adenocarcinoma Cells In Vitro","authors":"B. Filipič, L. Gradišnik, Klemen Rihar, A. Pereyra, Damir Đermić, H. Mazija","doi":"10.5772/intechopen.85777","DOIUrl":"https://doi.org/10.5772/intechopen.85777","url":null,"abstract":"The purpose was to investigate the influence of RJ-F(M), 10-hydroxy-2-decenoic acid and HuIFN- α N3 on the proliferation of CaCo-2 cells and ascertain their effects on intracellular glutathione level and lipid peroxidation. The antiproliferative (AP) activity of RJ-F (M) (0.1 g/10 mL PBS), HuIFN- α N3 (1000 IU mL −1 ), 10-HDA (100.0 μmol L −1 ) and their combinations, in the ratios 1:1, 1:2, and 2:1 on CaCo-2 cells were measured. Single RJ-F (M) had a low AP activity: 2.0 (0.5 mg mL −1 ). HuIFN- α N3 had an AP activity of 2.5 (208.33 IU mL −1 ), while 10-HDA had an AP activity of 1.5 (37.5 μmol mL −1 ). AP activity of 3.8 was obtained when RJ-F(M) and HuIFN- α N3 were in the ratio 2:1. In it, the level of GSH was 24.9 ± 2.4 nmol g −3 of proteins (vs. 70.2 ± 3.2 nmol g −3 in the control), and level of MDA was 72.3 ± 3.1 nmol g −3 (vs. 23.6 ± 9.1 nmol g −3 in the control). 10-HDA, together with HuIFN- α N3, is responsible for the inhibition of CaCo-2 cell proliferation in vitro . RJ-F (M) and HuIFN- α N3 applied at 2:1 decreased level of GSH and increased lipid peroxidation via MDA in CaCo-2 cells. Future studies are needed whether these GSH- and MDA-related activities of RJ-F (M), HuIFN- α N3, 10-HDA, and their combinations may decrease the tumorigenicity index and tumorigenic potential of tumor cells in vitro","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133214972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abubakar Babando Aliyu, Jonathan Ilemona Achika, Joseph Adesina Adewuyi, P. Gangas, H. Ibrahim, Adebayo Ojo Oyewale
{"title":"Antioxidants from Nigerian Medicinal Plants: What Are the Evidence?","authors":"Abubakar Babando Aliyu, Jonathan Ilemona Achika, Joseph Adesina Adewuyi, P. Gangas, H. Ibrahim, Adebayo Ojo Oyewale","doi":"10.5772/intechopen.84454","DOIUrl":"https://doi.org/10.5772/intechopen.84454","url":null,"abstract":"The search for natural antioxidants from plants would continue to be a dominant research interest for many years. This is because of the increasing understanding on the role of oxidative stress in damaging cell structures such as DNA, due to over production of free radicals and reactive oxygen species (ROS) in human systems, which are linked to inflammation, cancer and diabetes. However, phenolic compounds especially from phytochemicals or vegetable foods play important roles in reducing the risk of these diseases and reinforces the importance of natural antioxidants in human health. These antioxidant molecules neutralize or quench the ROS by either hydrogen atom transfer or single electron transfer mechanisms. Thus, the capacity to scavenge ROS and free radicals or inhibits lipid peroxidation is measured quantitatively as the strength of antioxidant activity. Several chemical and biochemical protocols have been used in the evaluation of plant extracts as antioxidants. Overwhelming literature reports have indicated varying degrees of antioxidant efficacies of extracts from Nigerian medicinal plants in comparison to synthetic antioxidants. These efficacies were analyzed to provide insight into the strength of antioxidant activity. This chapter reviewed 250 Nigerian medicinal plants in search of evidence for effective antioxidants.","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"142 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116537375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Statins Alone or in Combination with Ezetimibe or PCSK9 Inhibitors in Atherosclerotic Cardiovascular Disease Protection","authors":"M. Vavlukis, Ana Vavlukis","doi":"10.5772/INTECHOPEN.82520","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.82520","url":null,"abstract":"Statins have proved to be very effective in reducing atherosclerotic cardiovascular disease (ASCVD) risk, with no apparent threshold at which low-density lipoprotein cholesterol (LDL-C) lowering is not associated with a reduced risk. Yet, several meta-analyses of statin trials show significant on-treatment residual risk of major cardiovascular (CV) events. This finding points to the unmet needs, in terms of LDL-C targets and ASCVD protection, of statin-treated patients, raising the question of statin combination therapy. Ezetimibe is a cholesterol absorption inhibitor, with the potency to decrease LDL-C for about 10–18%, apolipoprotein B (apoB) for 11–16%, while, in combination therapy with statins, leads to an additional LDL-C lowering of 25%, with a total LDL-C lowering of 34–61%. It is also estimated that 10–20% of patients on statin treatment cannot tolerate them. As a result, adequate doses to achieve treatment target, or as recommended for the patient-specific risk profile, cannot be prescribed. Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibitors are monoclonal antibodies that inhibit the binding of PCSK9 to LDL-C receptors. Besides a very potent lipid-lowering effect, PCSK9 inhibitors have added ASCVD risk reduction benefit due to a very aggressive LDL-C lowering action, especially beneficial in patients who are intolerant to statins.","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114160980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lipid Peroxidation in Meat and Meat Products","authors":"A. L. F. Pereira, V. K. G. Abreu","doi":"10.5772/INTECHOPEN.81533","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.81533","url":null,"abstract":"The meat and meat products present a considerable amount of lipid in their composition. The lipid composition of these foods is diversified. Thus, depending on the type of meat, which can be rich in unsaturated fatty acid, there is an increase in the disposition for lipid oxidation. Oxidation reactions not only reduce the shelf life and nutritional value of food products but also can generate harmful compounds. Thus, having in view that many types of new technologies are applied to these foods, the proposal of this chapter of how these new methodologies have affected the lipid peroxidation of these foods. Moreover, the aim is to evaluate what impacts on the chemical characteristics of these foods. and","PeriodicalId":201791,"journal":{"name":"Lipid Peroxidation Research","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127248928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}